Skip to main content
. 2024 Jul 11;15(4):1948–1956. doi: 10.21037/jgo-24-222

Figure 3.

Figure 3

Timeline of the patient’s clinical progress showing major treatment modalities and disease status. HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; PVE, portal vein embolism; LLV, left liver volume; ICI, immune checkpoint inhibitor.